文献速递心境障碍

全国性目标试验模拟评估双相抑郁患者抗抑郁药所致躁狂风险

A Nationwide Target Trial Emulation Assessing the Risk of Antidepressant-Induced Mania Among Patients With Bipolar Depression.
PubMed 文献 · Am J Psychiatry · 2024-01-01

该研究利用丹麦全国健康登记观察数据模拟目标试验,纳入979例近期从精神科病房出院的双相抑郁患者,其中358例接受抗抑郁药治疗、621例未接受。完全校正分析显示,抗抑郁药治疗与躁狂风险在全样本、联合心境稳定剂亚组及未联合心境稳定剂亚组中均无统计学显著关联,二次分析亦未发现与双相抑郁复发的显著关联。

要点

  • 全样本中抗抑郁药与躁狂风险无统计学显著关联(HR=1.08,95%CI=0.72-1.61)。
  • 联合心境稳定剂亚组HR=1.16(95%CI=0.63-2.13),未联合亚组HR=1.16(95%CI=0.65-2.07)。
  • 二次分析未发现抗抑郁药与双相抑郁复发有统计学显著关联。

核心结论

  • 研究结果提示抗抑郁药所致躁狂的风险可忽略不计,并呼吁进一步研究以优化双相抑郁患者的治疗策略。

研究设计与样本

  • 采用丹麦全国健康登记观察数据模拟目标试验,纳入979例近期从精神科病房出院的双相抑郁患者,其中358例接受抗抑郁药治疗、621例未接受。
  • 通过Cox比例风险回归校正基线协变量以模拟随机开放标签治疗分配,分析抗抑郁药治疗的意向性治疗效应,随访1年内躁狂与双相抑郁的发生情况。

主要发现

  • 完全校正分析显示,全样本中抗抑郁药治疗与躁狂风险无统计学显著关联(HR=1.08,95%CI=0.72-1.61)。
  • 联合心境稳定剂亚组中抗抑郁药治疗与躁狂风险无统计学显著关联(HR=1.16,95%CI=0.63-2.13)。
  • 未联合心境稳定剂亚组中抗抑郁药治疗与躁狂风险无统计学显著关联(HR=1.16,95%CI=0.65-2.07)。
  • 二次分析显示抗抑郁药治疗与双相抑郁复发无统计学显著关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出随机对照试验证据受治疗持续时间短的限制,对长期抗抑郁药所致躁狂风险提供的证据有限。
  • 作者呼吁进一步研究以优化双相抑郁患者的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Antidepressants are commonly used to treat bipolar depression but may increase the risk of mania. The evidence from randomized controlled trials, however, is limited by short treatment durations, providing little evidence for the long-term risk of antidepressant-induced mania. The authors performed a target trial emulation to compare the risk of mania among individuals with bipolar depression treated or not treated with antidepressants over a 1-year period. METHODS: The authors emulated a target trial using observational data from nationwide Danish health registers. The study included 979 individuals with bipolar depression recently discharged from a psychiatric ward. Of these, 358 individuals received antidepressant treatment, and 621 did not. The occurrence of mania and bipolar depression over the following year was ascertained, and the intention-to-treat effect of antidepressants was analyzed by using Cox proportional hazards regression with adjustment for baseline covariates to emulate randomized open-label treatment allocation. RESULTS: The fully adjusted analyses revealed no statistically significant associations between treatment with an antidepressant and the risk of mania in the full sample (hazard rate ratio=1.08, 95% CI=0.72-1.61), in the subsample concomitantly treated with a mood-stabilizing agent (hazard rate ratio=1.16, 95% CI=0.63-2.13), and in the subsample not treated with a mood-stabilizing agent (hazard rate ratio=1.16, 95% CI=0.65-2.07). Secondary analyses revealed no statistically significant association between treatment with an antidepressant and bipolar depression recurrence. CONCLUSIONS: These findings suggest that the risk of antidepressant-induced mania is negligible and call for further studies to optimize treatment strategies for individuals with bipolar depression.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Rohde C, Østergaard SD, Jefsen OH, et al. A Nationwide Target Trial Emulation Assessing the Risk of Antidepressant-Induced Mania Among Patients With Bipolar Depression. Am J Psychiatry. 2024. PMID: 38946271. doi:10.1176/appi.ajp.20230477

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。